| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,516 |
1,461 |
$71K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,763 |
1,192 |
$54K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
314 |
284 |
$20K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
466 |
416 |
$15K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
180 |
170 |
$12K |
| S9083 |
Global fee urgent care centers |
86 |
71 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
322 |
309 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
740 |
371 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
682 |
661 |
$6K |
| 80305 |
|
748 |
364 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
17 |
16 |
$772.47 |
| 36415 |
Collection of venous blood by venipuncture |
297 |
278 |
$748.09 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14 |
14 |
$234.08 |
| 81025 |
|
42 |
41 |
$188.71 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
113 |
105 |
$106.38 |
| 99050 |
|
94 |
87 |
$87.07 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27 |
24 |
$51.33 |
| 81003 |
|
14 |
13 |
$1.50 |
| 99051 |
|
26 |
24 |
$0.00 |
| 99000 |
|
160 |
149 |
$0.00 |